0 items USD 0.00Search
Your search for "global markets direct refractory acute myeloid leukemia pipeline review h2 2016" gave back 28997 results.
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Acute Myeloid Leukemia market will undergo major changes...
Catalog:
Arsta
February 2023
Price: USD 3,490.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Acute Lymphoid Leukemia Treatment market will undergo...
Catalog:
Arsta
December 2022
Price: USD 3,550.00
This study focuses on China’s Leukemia Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
This study focuses on China’s Leukemia Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 1,800.00
China's demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will...
Catalog:
Asia Market Information & Development Co.
March 2018
Price: USD 4,000.00
The global neuromodulation market is poised to cross US$ 5 Billion mark by 2021. Neuromodulation is a technology that acts directly upon nerves. It...
Catalog:
iGATE
October 2016
Price: USD 1,250.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Myeloid Cells Targeting Therapeutics market will undergo...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Myeloid Cells Targeting Therapeutics market will undergo...
Catalog:
Arsta
January 2022
Price: USD 3,360.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
Diabetes has emerged as a major economic burden with high associated human and financial cost. It a chronic disease affecting millions of population...
Catalog:
Rockville Research
March 2017
Price: USD 1,100.00
China's demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will...
Catalog:
Asia Market Information & Development Co.
January 2023
Price: USD 4,000.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Chronic Lymphocytic Leukemia Drugs market will undergo...
Catalog:
Arsta
January 2023
Price: USD 3,490.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Chronic Eosinophilic Leukemia (CEL) Drugs market will...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Chronic Eosinophilic Leukemia (CEL) Drugs market will...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance...
MarketLine
June 2022
Price: USD 175.00
